,
your personalized virtual assistant to find clinical trials. Go head, 
Toni Choueiri, MD
Dana-Farber Cancer InstituteBoston, Massachusetts - 02115 Dana-Farber/Harvard Cancer Center at Dana ...Boston, Massachusetts - 02115 (617-632-4001) |
- CLINICAL TRIALS 6
- CONDITIONS8
- INTERVENTIONS14
- SINCE2007
Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma
January 2009 - September 2010
Arterial Spin Labeling Blood Flow MRI for Evaluation of Response to Antiangiogenic and Targeted Therapies of Renal Cell Carcinoma (RCC)
September 2008 - September 2010
Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma
December 2007 - December 2011
Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma
December 2008 - December 2010
Docetaxel With or Without Vandetanib in Treating Patients With Previously Treated Stage IV Transitional Cell Cancer
March 2007 - March 2010
Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma
March 2009 - January 2011
Neoplasms
Neoplasm Metastasis
Urinary Bladder Neoplasms
Carcinoma, Renal Cell
Kidney Neoplasms
Carcinoma
Carcinoma, Transitional Cell
Ureteral Neoplasms
Placebo
Cisplatin
Docetaxel
Methotrexate
Avastin
Temsirolimus
Everolimus
Gemcitabine
Pegfilgrastim
Sunitinib
Doxorubicin
Arterial Spin Labeling Magnetic Resonance Imaging
Vinblastine
Vandetanib
